Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Checking in on the Voxelator Launch With A Sickle Cell Expert (2 week delayed release to library)

Ticker(s): GBT

Who's the expert?

Name: Dr Richard Drachtman - MD

Institution: Rutgers Medical School

  • Interim Chief, Pediatric Hematology/Oncology and Director, Comprehensive Sickle Cell Center at Rutgers Cancer Institute of New Jersey; Vice Chair, IRB at Rutgers Biomedical and Health Sciences; and Vice Chair, NCI Pediatric Central IRB.
  • Currently manages 400 patients with sickle cell disease.
  • Research focuses on Hodgkin Disease, Pediatric oncology/ hematology, and Sickle cell disease.

Interview Questions
Q1.

Please describe your clinical practice; roughly how many patients with sickle cell disease do you currently manage

Added By: c_admin
Q2.

What you thought of the phase III results for voxelator?

Added By: c_admin
Q3.

Has payor approval been a concern for your patients?

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.